scholarly article | Q13442814 |
P50 | author | Howard Tennen | Q59975111 |
Henry R. Kranzler | Q67465892 | ||
Jonathan Covault | Q96647614 | ||
Joel Gelernter | Q30032479 | ||
P2093 | author name string | Stephen Armeli | |
Richard Feinn | |||
P2860 | cites work | Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study | Q44977108 |
The relationship between coping strategies, alcohol expectancies, drinking motives and drinking behaviour | Q48155064 | ||
Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial. | Q50697707 | ||
Drinking habits and expectancies about alcohol's effects for self versus others. | Q52279443 | ||
Relation of alcohol expectancies to changes in problem drinking among college students. | Q53720898 | ||
Comprehensive effects of alcohol: Development and psychometric assessment of a new expectancy questionnaire | Q56553453 | ||
Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism | Q95805364 | ||
An integrated map of genetic variation from 1,092 human genomes | Q22122153 | ||
Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution | Q24289449 | ||
Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers | Q24672412 | ||
Glutamatergic targets for new alcohol medications | Q26824012 | ||
A general multilevel SEM framework for assessing multilevel mediation | Q28292564 | ||
Topiramate blocks kainate-evoked cobalt influx into cultured neurons | Q28376946 | ||
Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons | Q28572670 | ||
Topiramate for treating alcohol dependence: a randomized controlled trial | Q30444701 | ||
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial | Q30446318 | ||
Hierarchical modeling of sequential behavioral data: examining complex association patterns in mediation models | Q31125453 | ||
A review of expectancy theory and alcohol consumption | Q31934361 | ||
Measurement of admixture proportions and description of admixture structure in different U.S. populations | Q33839183 | ||
The neurobiology of alcohol consumption and alcoholism: an integrative history | Q34378869 | ||
Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment | Q36322822 | ||
The predictive validity of the Drinking-Related Cognitions Scale in alcohol-dependent patients under abstinence-oriented treatment | Q36367755 | ||
5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity | Q36625432 | ||
Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity | Q36999739 | ||
Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence | Q37410610 | ||
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism | Q37719175 | ||
Development and initial validation of a measure of drinking urges in abstinent alcoholics | Q39474611 | ||
Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study | Q40131864 | ||
Do good things come to those who drink? A longitudinal investigation of drinking expectancies and hazardous alcohol use in female college athletes | Q40305261 | ||
The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior | Q42685745 | ||
Alcohol expectancy and hazardous drinking: a 6-year longitudinal and nationwide study of medical doctors | Q43249032 | ||
Patterns of alcohol expectancies and alcohol use across age and gender | Q44441824 | ||
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial | Q44454640 | ||
Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior | Q44853625 | ||
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist | Q44864684 | ||
Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons | Q44870767 | ||
P433 | issue | 10 | |
P304 | page(s) | 1549-1556 | |
P577 | publication date | 2014-04-30 | |
P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
P1476 | title | GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink | |
P478 | volume | 17 |
Q93082377 | Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer's Disease Model Mice, APP/PS1 |
Q35553786 | Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments |
Q26799837 | Ecological Momentary Assessment and Alcohol Use Disorder Treatment |
Q47616594 | GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers |
Q34609200 | GRIK1 genotype and daily expectations of alcohol's positive effects moderate the reduction of heavy drinking by topiramate |
Q38269776 | Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis |
Q34643464 | Genetic variants of glutamate receptor gene family in Taiwanese Kawasaki disease children with coronary artery aneurysms |
Q92354717 | Pharmacogenetics of alcohol addiction: current perspectives |
Q34941610 | Posttreatment effects of topiramate treatment for heavy drinking. |
Q35744334 | Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking |
Q41468981 | The effects of single nucleotide polymorphisms in glutamatergic neurotransmission genes on neural response to alcohol cues and craving |
Q51144124 | Using Ecological Momentary Assessment to Identify Mechanisms of Change: An Application From a Pharmacotherapy Trial With Adolescent Cannabis Users. |
Q53414378 | Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment. |
Search more.